ClinicalTrials.Veeva

Menu

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

T

Tang-Du Hospital

Status

Unknown

Conditions

Non Small Cell Lung Cancer

Treatments

Procedure: Surgeries

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03427541
WTONG05

Details and patient eligibility

About

An observational study to explore prognoses and clinical treatments of the patients with non-small cell lung cancer complicated with oligometastases

Full description

A multi-centre real-world non-interventional observational study to explore prognoses and clinical treatments of the patients with non-small lung cancer complicated with oligometastases

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pathologically diagnosed patients with non-small cell lung cancer;
  • Tumor metastases in one organ (no more than 3 metastases);

Exclusion criteria

  • Patients with intrapulmonary metastases or multiple primary tumors;
  • Patients with pleural dissemination or invasion of extrapulmonary organs;
  • Patients with supraclavicular lymph node metastasis;
  • Patients with systematic diseases that would influence patient survivals;
  • Patients with no records for visits;

Trial design

1,000 participants in 1 patient group

Patients with surgeries
Description:
NSCLC patients with surgeries
Treatment:
Procedure: Surgeries

Trial contacts and locations

10

Loading...

Central trial contact

Haiying Yang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems